Literature DB >> 15673780

Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.

Carmen Ardanuy1, Fe Tubau, Josefina Liñares, María Angeles Domínguez, Román Pallarés, Rogelio Martín.   

Abstract

The distribution of subclasses mefA and mefE of the mefA gene among 116 M-phenotype streptococci was as follows: pneumococci (38 strains had mefE and 4 mefA), viridans streptococci (49 mefE and 1 mefA), and Streptococcus pyogenes (24 mefA). Spain(9V)-3-14 and England(14)-9 clones of serotype 14 were dominant among pneumococci.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15673780      PMCID： PMC547321          DOI： 10.1128/AAC.49.2.827-829.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Incidence of mefA and mefE genes in viridans group streptococci.

Authors:  C Arpin; M H Canron; J Maugein; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Distribution of resistance genes tet(M), aph3'-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain.

Authors:  C Seral; F J Castillo; M C Rubio-Calvo; A Fenoll; C García; R Gómez-Lus
Journal:  J Antimicrob Chemother       Date:  2001-06       Impact factor: 5.790

5.  Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae.

Authors:  M Del Grosso; F Iannelli; C Messina; M Santagati; N Petrosillo; S Stefani; G Pozzi; A Pantosti
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults.

Authors:  E Pérez-Trallero; D Vicente; M Montes; J M Marimon; L Piñeiro
Journal:  J Antimicrob Chemother       Date:  2001-08       Impact factor: 5.790

7.  Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).

Authors:  J J Granizo; L Aguilar; J Casal; C García-Rey; R Dal-Ré; F Baquero
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

8.  Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region.

Authors:  Tracey J Coffey; Margaret Daniels; Mark C Enright; Brian G Spratt
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

9.  Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

Authors:  Kelley A Gordon; Mondell L Beach; Douglas J Biedenbach; Ronald N Jones; Paul R Rhomberg; Alan H Mutnick
Journal:  Diagn Microbiol Infect Dis       Date:  2002-06       Impact factor: 2.803

10.  Molecular characterization of erythromycin-resistant clinical isolates of the four major antimicrobial-resistant Spanish clones of Streptococcus pneumoniae (Spain23F-1, Spain6B-2, Spain9V-3, and Spain14-5).

Authors:  José M Marimón; Luis Iglesias; Diego Vicente; Emilio Pérez-Trallero
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431
View more
  7 in total

1.  Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone.

Authors:  C Ardanuy; A Fenoll; S Berrón; L Calatayud; J Liñares
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I).

Authors:  Ileana Cochetti; Manuela Vecchi; Marina Mingoia; Emily Tili; Maria R Catania; Aldo Manzin; Pietro E Varaldo; Maria Pia Montanari
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 3.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

4.  Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  M Figueira; P Fernandes; S I Pelton
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

5.  Antibiotic Resistance Patterns and Related Mobile Genetic Elements of Pneumococci and β-Hemolytic Streptococci in Thai Healthy Children.

Authors:  P Tantivitayakul; J Lapirattanakul; T Vichayanrat; T Muadchiengka
Journal:  Indian J Microbiol       Date:  2016-06-30       Impact factor: 2.461

6.  Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.

Authors:  Laura Calatayud; C Ardanuy; E Cercenado; A Fenoll; E Bouza; R Pallares; R Martín; J Liñares
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

7.  Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture.

Authors:  Elisabetta Caselli; Chiara Fabbri; Maria D'Accolti; Irene Soffritti; Cristian Bassi; Sante Mazzacane; Maurizio Franchi
Journal:  BMC Microbiol       Date:  2020-05-18       Impact factor: 3.605
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.